The Global Fibromyalgia Treatment Market Growth Accelerated By Rising Adoption Of Non-Pharmacological Therapies

Fibromyalgia Treatment Market 

 Fibromyalgia is a musculoskeletal disorder characterized by widespread pain, fatigue, sleep, memory and mood issues. Non-pharmacological fibromyalgia treatment includes therapies like physical therapy, meditation, acupuncture and yoga. These therapies help enhance physical functioning, reduce depression and anxiety and improve sleep quality. With growing awareness about the benefits of non-drug therapies for pain management, their adoption has been increasing significantly.


The global Fibromyalgia Treatment Market is estimated to be valued at US$ 1546.59 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The rising adoption of non-pharmacological therapies is one of the major trends being witnessed in the global fibromyalgia treatment market. According to recent studies, meditation, physical exercise and mindfulness-based cognitive behavior therapy have shown effectiveness equivalent to commonly prescribed medications for fibromyalgia symptoms relief. They offer sustainable pain management with negligible side-effects. As a result, there is growing inclination among healthcare practitioners and patients towards non-drug alternatives. This growing preference for integrated therapeutic approaches using non-pharmacological techniques in fibromyalgia care is expected to drive significant growth of the overall market during the forecast period.

Segment Analysis
The global fibromyalgia treatment market is segmented on the basis of treatment, route of administration, and distribution channel. The treatment segment is further divided into medications and therapies. Medications are the dominating sub-segment owing to the high adoption of prescription drugs for fibromyalgia treatment. Key prescription drugs used in fibromyalgia treatment include duloxetine, pregabalin, milnacipran, and savella.

Key Takeaways
The global fibromyalgia treatment market analysis is expected to witness high growth over the forecast period of 2023 to 2030. The global Fibromyalgia Treatment Market is estimated to be valued at US$ 1546.59 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030.

Regional analysis: North America is currently the dominant region in the global fibromyalgia treatment market and is expected to continue its dominance over the forecast period. This is attributed to the increasing prevalence of fibromyalgia and higher adoption of advanced treatment options in the region. Europe is also expected to witness above-average growth owing to growing awareness regarding available fibromyalgia treatment options. Asia Pacific is estimated to be the fastest-growing region due to rising healthcare expenditure and increasing patient pool.

Key players: Key players operating in the fibromyalgia treatment market include Autodesk Inc., IES (Integrated Environmental Solutions), Bentley Systems, EnergyPlus, CY
PE Software, DesignBuilder Software, IESVE (IES Virtual Environment), Carrier, eQUEST, Trane Technologies, IES TaP, IES SCAN, Trimble, and EnergySoft. Autodesk Inc., Bentley Systems, and Trimble collectively account for the dominant market share currently due to their extensive product portfolios for structural design and construction management.

 

Comments

Popular posts from this blog

Increasing aircrafts deliveries to fuel the growth of Aircraft Radome Market

The Global Cryocooler Market Growth Accelerated By Rising Demand From Aerospace And Military Industries

The Global Dutch Brick Market Growth Accelerated By Increase In Residential Construction